Cite
MLA Citation
Giuseppina Milano et al.. “Intravenous administration of cardiac progenitor cell-derived exosomes protects against doxorubicin/trastuzumab-induced cardiac toxicity.” Cardiovascular research, vol. 116, no. 2, 2020, pp. 383–392. http://access.bl.uk/ark:/81055/vdc_100099430955.0x00005b